Earlier visibility into feasibility, recruitment potential and protocol risk.
Start a conversation ↗Strategic direction
Clinical intelligence.
Built for what comes next.
Strengthening research decisions through connected expertise, integrated data and responsible innovation.
Beyond the traditional CRO
Building the next generation of clinical intelligence.
Questra aims to evolve into an AI-enabled clinical research ecosystem anchored in Malaysia and designed for Southeast Asia.
Our development direction connects scientific judgement, harmonised study data and responsible automation across feasibility, recruitment, protocol-risk detection, deviation monitoring, pharmacovigilance, imaging and real-world evidence.
The objective is practical: identify risk earlier, improve visibility during execution and help experienced teams make more timely, informed decisions.
Technology is intended to strengthen—not replace—clinical, scientific and regulatory judgement. Quality, participant safety and trustworthy evidence remain the foundation.
More timely operational and quality signals throughout study execution.
Longer-term capability in real-world evidence, imaging and integrated clinical insight.
Malaysia · ASEAN · Global sponsors
A regional platform, anchored in Malaysia.
Questra’s Penang base combines Malaysia-led clinical and bioequivalence operations with a wider Southeast Asian outlook. We aim to give sponsors a responsive local partner that understands regional execution while working to internationally recognised quality standards.
MalaysiaSingaporeIndonesiaThailandVietnamGlobal sponsors